Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 Antagonists

被引：2
|
作者：
Valentini, Alice [3 ]
Schultz-Knudsen, Katrine [3 ]
Hansen, Anders Hojgaard [2 ]
Tsakoumagkou, Argyro [3 ]
Jenkins, Laura [1 ]
Christensen, Henriette B. [2 ]
Manandhar, Asmita [3 ]
Milligan, Graeme [1 ]
Ulven, Trond [2 ,3 ]
Ulven, Elisabeth Rexen [3 ]
机构：
[1] Univ Glasgow, Coll Med Vet & Life Sci, Ctr Translat Pharmacol, Sch Mol Biosci, Glasgow G12 8QQ, Scotland
[2] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense M, Denmark
[3] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 66卷 / 09期
基金：
英国生物技术与生命科学研究理事会;
关键词：
FFA2; ANTAGONIST; FUNCTIONAL-CHARACTERIZATION; GLUCOSE-TOLERANCE; GUT MICROBIOTA; DIETARY FIBER; AGONIST; GPR43; IDENTIFICATION; GLPG0974; SAFETY;
D O I：
10.1021/acs.jmedchem.2c01935
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The free fatty acid receptor 2 (FFA2), also known as GPR43, mediates effects of short-chain fatty acids and has attracted interest as a potential target for treatment of various metabolic and inflammatory diseases. Herein, we report the results from bioisosteric replacement of the carboxylic acid group of the established FFA2 antagonist CATPB and SAR investigations around these compounds, leading to the discovery of the first high potency FFA2 antagonists, with the preferred compound TUG 2304 (16l) featuring IC50 values of 3-4 nM in both cAMP and GTP gamma S assays, favorable physicochemical and pharmacokinetic properties, and the ability to completely inhibit propionate induced neutrophil migration and respiratory burst.
引用
收藏
页码：6105 / 6121
页数：17
相关论文
共 50 条
  • [31] Discovery of novel and potent CRTH2 antagonists
    Ito, Shinji
    Terasaka, Tadashi
    Zenkoh, Tatsuya
    Matsuda, Hiroshi
    Hayashida, Hisashi
    Nagata, Hiroshi
    Imamura, Yoshimasa
    Kobayashi, Miki
    Takeuchi, Makoto
    Ohta, Mitsuaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1194 - 1197
  • [32] Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists
    Wang, Lingyan
    Song, Tianqing
    Wang, Xin
    Li, Jiazhong
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [33] Discovery of potent, non-peptide thrombin receptor antagonists.
    Chackalamannil, S
    Xia, Y
    Clasby, M
    Greenlee, W
    Doller, D
    Eagen, K
    Tsai, HS
    Asberom, T
    Lin, Y
    Czarniecki, M
    Ahn, HS
    Foster, C
    Boykow, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U60 - U60
  • [34] The discovery of potent and selective dopamine D4 receptor antagonists
    Faraci, WS
    Zorn, SH
    Sanner, MA
    Fliri, A
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) : 535 - 540
  • [35] Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists
    Yang, Christine
    Shen, Hong C.
    Wu, Zhicai
    Chu, Hong D.
    Cox, Jason M.
    Balsells, Jaume
    Crespo, Alejandro
    Brown, Patricia
    Zamlynny, Beata
    Wiltsie, Judyann
    Clemas, Joseph
    Gibson, Jack
    Contino, Lisa
    Lisnock, JeanMarie
    Zhou, Gaochao
    Garcia-Calvo, Margarita
    Bateman, Tom
    Xu, Ling
    Tong, Xinchun
    Crook, Martin
    Sinclair, Peter
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (15) : 4388 - 4392
  • [36] Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor
    Bedford, Simon T.
    Benwell, Karen R.
    Brooks, Teresa
    Chen, Ijen
    Comer, Mike
    Dugdale, Sarah
    Haymes, Tim
    Jordan, Allan M.
    Kennett, Guy A.
    Knight, Anthony R.
    Klenke, Burkhard
    LeStrat, Loic
    Merrett, Angela
    Misra, Anil
    Lightowler, Sean
    Padfield, Anthony
    Poullennec, Karine
    Reece, Mark
    Simmonite, Heather
    Wong, Melanie
    Yule, Ian A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (20) : 5945 - 5949
  • [37] Discovery of a new series of potent and selective linear tachykinin NK2 receptor antagonists
    Fedi, Valentina
    Altamura, Maria
    Catalioto, Rose-Marie
    Giannotti, Danilo
    Giolitti, Alessandro
    Giuliani, Sandro
    Guidi, Antonio
    Harmat, Nicholas J. S.
    Lecci, Alessandro
    Meini, Stefania
    Nannicini, Rossano
    Pasqui, Franco
    Tramontana, Manuela
    Triolo, Antonio
    Maggi, Carlo Alberto
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (20) : 4793 - 4807
  • [38] Discovery of a Potent Free Fatty Acid 1 Receptor Agonist with Low Lipophilicity, Low Polar Surface Area, and Robust in Vivo Efficacy
    Hansen, Steffen V. F.
    Christiansen, Elisabeth
    Urban, Christian
    Hudson, Brian D.
    Stocker, Claire J.
    Due-Hansen, Maria E.
    Wargent, Ed T.
    Shimpukade, Bharat
    Almeida, Reinaldo
    Ejsing, Christer S.
    Cawthorne, Michael A.
    Kassack, Matthias U.
    Milligan, Graeme
    Ulven, Trond
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (06) : 2841 - 2846
  • [39] Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists
    Williams, Jodi T.
    Gatfield, John
    Roch, Catherine
    Treiber, Alexander
    Jenck, Francois
    Bolli, Martin H.
    Brotschi, Christine
    Sifferlen, Thierry
    Heidmann, Bibia
    Boss, Christoph
    MEDCHEMCOMM, 2015, 6 (06) : 1054 - 1064
  • [40] Discovery, synthesis and in combo studies of a tetrazole analogue of clofibric acid as a potent hypoglycemic agent
    Navarrete-Vazquez, Gabriel
    Alaniz-Palacios, Alfredo
    Hidalgo-Figueroa, Sergio
    Gonzalez-Acevedo, Cristina
    Avila-Villarreal, Gabriela
    Estrada-Soto, Samuel
    Webster, Scott P.
    Medina-Franco, Jose L.
    Lopez-Vallejo, Fabian
    Guerrero-Alvarez, Jorge
    Tlahuext, Hugo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (11) : 3244 - 3247
12345